reference/14909563

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14909563

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Clinical Trial, Phase II\|Journal Article\|Multicenter Study
endingPage	e394
issn	2352-3026
issueIdentifier	5
pageRange	e381-e394
publicationName	The Lancet. Haematology
startingPage	e381
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a6076db62ee4fa11a2c6fb7d69d18b8
bibliographicCitation	Raab MS, Engelhardt M, Blank A, Goldschmidt H, Agis H, Blau IW, Einsele H, Ferstl B, Schub N, Röllig C, Weisel K, Winderlich M, Griese J, Härtle S, Weirather J, Jarutat T, Peschel C, Chatterjee M. MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1-2a trial. Lancet Haematol. 2020 May;7(5):e381–94. doi: 10.1016/s2352-3026(19)30249-2. PMID: 32171061.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_422831065962a03fe65a57f27d9ef3c6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f86136515be8f091b65b1552c73d00fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_496eb2b5c3e0a1788dfdf1e91754cfb4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_411db791561c2df26bdfe7ae02d04bd0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cec57e29d0ada2cd21fe4ad4b95176f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4e6884ba3a314fd4e98fc3956605760d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f977b763a08c549a87c3e26213bfc44c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_211126ee799b7c032564e51e097393d2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de6ac3f0016535052ef0fe9c8cba2d28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_751ea4e7fc6c6c2391cee1e472b4f77d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0dcee644972191dd5c40bce1dae2e158 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b16166492808d69609009f75cb2d018f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c01258cc8c67ffaf942087da60ca694a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_460495eac45c371a67a7762c71dda31d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_74f81d7cb4aa43fffb2d020e4a15a5d5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44f1610ca61d6aad852ee8866c733f70 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13e8069363fb63936a6963cd4173ab85 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_948fd125b0159c519639a1bb006e9ceb
date	202005
identifier	https://pubmed.ncbi.nlm.nih.gov/32171061 https://doi.org/10.1016/s2352-3026%2819%2930249-2
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/43133 https://portal.issn.org/resource/ISSN/2352-3026
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial
discusses	http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0006099 http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0160285 http://id.nlm.nih.gov/mesh/M0441603 http://id.nlm.nih.gov/mesh/M000736702 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0479831 http://id.nlm.nih.gov/mesh/M000626416
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D061067Q000627 http://id.nlm.nih.gov/mesh/D009101Q000188 http://id.nlm.nih.gov/mesh/D000074322Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D051997Q000037 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000077269Q000627 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013792Q000031 http://id.nlm.nih.gov/mesh/D009364Q000188 http://id.nlm.nih.gov/mesh/D013792Q000627 http://id.nlm.nih.gov/mesh/D000971Q000627 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D003907Q000627 http://id.nlm.nih.gov/mesh/D000970Q000627
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5743 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216326 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134780 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6fab6bf193c862d5cac8dd80e83ceb7a http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8392 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8321

Showing number of triples: 1 to 70 of 70.